Author/Authors :
Goodarz Danaei، نويسنده , , Carlene MM Lawes، نويسنده , , Stephen Vander Hoorn، نويسنده , , Christopher JL Murray and the Comparative Risk Assessment Collaborating Group، نويسنده , , Majid Ezzati، نويسنده ,
Abstract :
Background
Cardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of